NexgenRx Inc. repaid C$1.25 million of a C$1.75 million secured loan obtained from an "arm's length shareholder" in connection with the company's acquisitions announced in July 2018.
The lender agreed to amend and extend its secured loan for the remaining C$500,000, with the interest rate being 6% payable over 24 months to maturity on Aug. 31, 2021.
The repayment was funded through cash on hand and unsecured loans from three insiders, namely CEO Ron Loucks and two arms-length shareholders. The unsecured loans bear 8% interest per annum and are payable quarterly. The loans mature Oct. 15, 2020.